Fosamax
Current News
Sep-05-06: Bisphosphonates such as Fosamax, have been linked to Osteonecrosis of the jaw (ONJ). [NEWS INFERNO - FOSAMAX]
Aug-06-06: Doctors continue to prescribe Fosamax in spite of rare but devastating jaw bone disease. [STATESMAN - FOSAMAX]
Jul-30-06: Fosamax linked to rare condition: when jawbone is exposed it won't heal. [DALLAS NEWS - FOSAMAX]
Jul-27-06: Simple tooth extractions can lead to painful jaw disease for those taking Fosamax. [SMH - FOSAMAX]
Jul-13-06: Merck's President of US Health, Brad Sheares, leaves company. Sheares was responsible for primary care products such as Fosamax. [YAHOO - FOSAMAX]
Jul-05-06: Dentists become more vigilant about asking patients if they are taking Fosamax, as incidents of "dead jaw" increase. [MONTEREY HERALD - FOSAMAX]
Jun-26-06: Fosamax controversy is a boon for alternate bone health supplements. [YAHOO - FOSAMAX]
Jun-25-06: Dentists find increasing occurances of dead jaw in patients who use bisphosphonates such as Fosamax. [THE STATE - FOSAMAX]
Jun-15-06: Doctors need more info about bisphosphonates such as Fosamax that allegedly cause jaw bone death. [COURIER-JOURNAL - FOSAMAX]
May-10-06: 15 Foxamax Lawsuits have been filed so far, and many more are likely to follow. [CNN - FOSAMAX]
May-06-06: Fosamax lawsuits are piling up claiming the drug causes patients' jawbones to decay. [TENNESSEAN - FOSAMAX]
May-05-06: Health Canada is adding new warnings to bone density drugs, which may cause jaw bones to die. [CBC - FOSAMAX]
Apr-15-06: Fosamax Lawsuit claims Merck marketed Fosamax as safe, and hid dangerous side effects of Osteonecrosis of the jaw. [PLAYFULS - FOSAMAX]
|
 |
|
Do You Have A Potential Fosamax Case?
Contact Us Today! |
 |
Fosamax
Current News
Jaw disease may be linked to osteoporosis drugs
Bone specialists this month convened a task force to investigate a rare but troubling side effect apparently associated with widely used osteoporosis medications: jaw bone that won't heal once it is exposed. Almost 95 percent of the known cases have occurred among cancer patients taking the drugs ...read more
Another Merck Drug Is Under Legal Attack
As Merck & Co. defends itself against a deluge of litigation involving its pain reliever Vioxx, the pharmaceutical giant also is fielding the first of what could be another wave of lawsuits involving Fosamax, its second-biggest seller. The emerging litigation targeting the osteoporosis drug ...read more
|
|
|
